Patents Assigned to Verrow Pharmaceuticals, Inc.
  • STABILIZED FORMULATIONS CONTAINING IODINATED CONTRAST AGENTS AND CYCLODEXTRINS
    Publication number: 20140377185
    Abstract: The invention encompasses compositions containing an iodinated contrast agent and a substituted cyclodextrin wherein the cyclodextrin stabilizes the contrast agent against degradation by ultraviolet or visible light exposure.
    Type: Application
    Filed: March 6, 2013
    Publication date: December 25, 2014
    Applicant: VERROW PHARMACEUTICALS, INC.
    Inventor: Gerold L. Mosher
  • STABILIZED FORMULATIONS CONTAINING IODINATED CONTRAST AGENTS AND CYCLODEXTRINS
    Publication number: 20130323181
    Abstract: The invention encompasses compositions containing an iodinated contrast agent and a substituted cyclodextrin wherein the cyclodextrin stabilizes the contrast agent against degradation by ultraviolet or visible light exposure.
    Type: Application
    Filed: March 6, 2013
    Publication date: December 5, 2013
    Applicant: VERROW PHARMACEUTICALS, INC.
    Inventor: Gerold L. Mosher
  • Compositions useful for reducing nephrotoxicity and methods of use thereof
    Patent number: 8574551
    Abstract: The present invention provides compositions and methods to reduce renal damage caused by nephrotoxic drugs. The invention provides compositions comprising an anionically substituted cyclodextrin, a nephrotoxic drug and a pharmaceutically acceptable carrier, where the cyclodextrin is present in an amount effective for substantially inhibiting the nephrotoxic effect of the drug.
    Type: Grant
    Filed: August 23, 2012
    Date of Patent: November 5, 2013
    Assignee: Verrow Pharmaceuticals, Inc.
    Inventor: Vernon D. Rowe
  • Compositions Useful for Reducing Nephrotoxicity and Methods of Use Thereof
    Publication number: 20120321564
    Abstract: The present invention provides compositions and methods to reduce renal damage caused by nephrotoxic drugs. The invention provides compositions comprising an anionically substituted cyclodextrin, a nephrotoxic drug and a pharmaceutically acceptable carrier, where the cyclodextrin is present in an amount effective for substantially inhibiting the nephrotoxic effect of the drug.
    Type: Application
    Filed: August 23, 2012
    Publication date: December 20, 2012
    Applicant: Verrow Pharmaceuticals, Inc.
    Inventor: Vernon D. Rowe
  • Compositions useful for reducing toxicity associated with gadolinium-based contrast agents
    Patent number: 8192721
    Abstract: The invention relates to compositions comprising a gadolinium-based contrast agent and a derivatized cyclodextrin. Further provided are methods for reducing the toxicity associated with gadolinium-based contrast agents.
    Type: Grant
    Filed: December 11, 2008
    Date of Patent: June 5, 2012
    Assignee: Verrow Pharmaceuticals, Inc.
    Inventor: Vernon D. Rowe
  • Methods of Reducing Methotrexate Nephrotoxicity
    Publication number: 20110028413
    Abstract: The present invention provides compositions and methods to reduce renal damage caused by nephrotoxic drugs such as methotrexate. The invention provides compositions comprising a substituted cyclodextrin, methotrexate and a pharmaceutically acceptable carrier, where the cyclodextrin is present in an amount effective for substantially inhibiting the nephrotoxic effect of the methotrexate.
    Type: Application
    Filed: October 13, 2010
    Publication date: February 3, 2011
    Applicant: VERROW PHARMACEUTICALS, INC.
    Inventor: Vernon D. Rowe
  • Methods for Reducing Cisplatin Nephrotoxicity
    Publication number: 20110027390
    Abstract: The present invention provides compositions and methods to reduce renal damage caused by nephrotoxic drugs such as cisplatin. The invention provides compositions comprising a substituted cyclodextrin, cisplatin and a pharmaceutically acceptable carrier, where the cyclodextrin is present in an amount effective for substantially inhibiting the nephrotoxic effect of the cisplatin.
    Type: Application
    Filed: October 13, 2010
    Publication date: February 3, 2011
    Applicant: VERROW PHARMACEUTICALS, INC.
    Inventor: Vernon D. Rowe
  • COMPOSITIONS USEFUL FOR REDUCING NEPHROTOXICITY AND METHODS OF USE THEREOF
    Publication number: 20100093664
    Abstract: The present invention provides compositions and methods to reduce renal damage caused by nephrotoxic drugs. The invention provides compositions comprising an anionically substituted cyclodextrin, a nephrotoxic drug and a pharmaceutically acceptable carrier, where the cyclodextrin is present in an amount effective for substantially inhibiting the nephrotoxic effect of the drug.
    Type: Application
    Filed: December 18, 2009
    Publication date: April 15, 2010
    Applicant: VERROW PHARMACEUTICALS, INC.
    Inventor: Vernon D. Rowe
  • Compositions useful for reducing nephrotoxicity and methods of use thereof
    Patent number: 7658913
    Abstract: The present invention provides compositions and methods to reduce renal damage caused by nephrotoxic drugs. The invention provides compositions comprising a substituted cyclodextrin, a nephrotoxic drug and a pharmaceutically acceptable carrier, where the cyclodextrin is present in an amount effective for substantially inhibiting the nephrotoxic effect of the drug.
    Type: Grant
    Filed: May 25, 2007
    Date of Patent: February 9, 2010
    Assignee: Verrow Pharmaceuticals, Inc.
    Inventor: Vernon D. Rowe
  • Compositions Useful for Reducing Toxicity Associated with Gadolinium-based Contrast Agents
    Publication number: 20090155181
    Abstract: The invention relates to compositions comprising a gadolinium-based contrast agent and a derivatized cyclodextrin. Further provided are methods for reducing the toxicity associated with gadolinium-based contrast agents.
    Type: Application
    Filed: December 11, 2008
    Publication date: June 18, 2009
    Applicant: Verrow Pharmaceuticals, Inc.
    Inventor: Vernon D. Rowe